{"transactions":[{"id":1523509,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2024-05-08T20:48:22.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":false,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each RSU represents a contingent right to receive one (1) share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a \"Change of Control\" under the terms of the RSU award agreement, the vesting of the RSUs accelerated."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Pursuant to the terms of the award, as a result of the closing of the sale of substantially all of the assets of the Company to Bruker Corporation, which constituted a \"Change of Control\" under the terms of the RSU award agreement, the vesting of the RSUs accelerated."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001401708-24-000086","document":"wk-form4_1715215692.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000140170824000086/wk-form4_1715215692.xml","form_type":"4"}},{"id":1523508,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2024-05-08T20:48:22.000Z","date":"2024-05-06","kind":"exercise","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares have not been delivered to the reporting person."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001401708-24-000086","document":"wk-form4_1715215692.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000140170824000086/wk-form4_1715215692.xml","form_type":"4"}},{"id":1795461,"issuer":{"id":15988,"kind":"organization","name":"NanoString Technologies Inc","symbol":"NSTG"},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-28T16:26:32.000Z","date":"2023-08-28","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one (1) share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"1/3 of the RSUs vest on or following the first anniversary of August 28, 2023 (the \"RSU Vesting Commencement Date\"), and 1/3 of the RSUs vest annually each year on or after the second and third anniversary of the RSU Vesting Commencement Date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"1/3 of the RSUs vest on or following the first anniversary of August 28, 2023 (the \"RSU Vesting Commencement Date\"), and 1/3 of the RSUs vest annually each year on or after the second and third anniversary of the RSU Vesting Commencement Date."}],"balance_after":200000,"derivative":{"underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001401708-23-000210","document":"wk-form4_1693254360.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000140170823000210/wk-form4_1693254360.xml","form_type":"4"}},{"id":1800963,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-21T20:10:09.000Z","date":"2023-08-18","kind":"exercise","planned":false,"acquired":false,"shares":2761,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to the RSU Award shall vest over four years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."}],"balance_after":39579,"derivative":{"underlying":"Common Stock","underlying_shares":2761},"source":{"system":"sec-edgar","filing":"0001209191-23-046826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123046826/doc4.xml","form_type":"4"}},{"id":1800962,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-08-21T20:10:09.000Z","date":"2023-08-18","kind":"exercise","planned":false,"acquired":false,"shares":1951,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 12/48th of the total shares underlying the RSU Award vesting on May 18, 2023 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 12/48th of the total shares underlying the RSU Award vesting on May 18, 2023 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":21462,"derivative":{"underlying":"Common Stock","underlying_shares":1951},"source":{"system":"sec-edgar","filing":"0001209191-23-046826","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123046826/doc4.xml","form_type":"4"}},{"id":1800961,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-21T20:10:09.000Z","date":"2023-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1076,"price":8.46,"value":9102.96,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":8763,"source":{"system":"sec-edgar","filing":"0001209191-23-046826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123046826/doc4.xml","form_type":"4"}},{"id":1800960,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-21T20:10:09.000Z","date":"2023-08-18","kind":"exercise","planned":false,"acquired":true,"shares":2761,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":9839,"source":{"system":"sec-edgar","filing":"0001209191-23-046826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123046826/doc4.xml","form_type":"4"}},{"id":1800959,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-21T20:10:09.000Z","date":"2023-08-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":760,"price":8.46,"value":6429.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on August 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":7078,"source":{"system":"sec-edgar","filing":"0001209191-23-046826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123046826/doc4.xml","form_type":"4"}},{"id":1800958,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-08-21T20:10:09.000Z","date":"2023-08-18","kind":"exercise","planned":false,"acquired":true,"shares":1951,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":7838,"source":{"system":"sec-edgar","filing":"0001209191-23-046826","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123046826/doc4.xml","form_type":"4"}},{"id":1884992,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-19T19:02:41.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":false,"shares":1840,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."}],"balance_after":42340,"derivative":{"underlying":"Common Stock","underlying_shares":1840},"source":{"system":"sec-edgar","filing":"0001209191-23-031260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123031260/doc4.xml","form_type":"4"}},{"id":1884991,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-05-19T19:02:41.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":false,"shares":7804,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 12/48th of the total shares underlying the RSU Award vesting on May 18, 2023 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 12/48th of the total shares underlying the RSU Award vesting on May 18, 2023 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":23413,"derivative":{"underlying":"Common Stock","underlying_shares":7804},"source":{"system":"sec-edgar","filing":"0001209191-23-031260","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123031260/doc4.xml","form_type":"4"}},{"id":1884990,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T19:02:41.000Z","date":"2023-05-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":717,"price":6.69,"value":4796.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":5887,"source":{"system":"sec-edgar","filing":"0001209191-23-031260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123031260/doc4.xml","form_type":"4"}},{"id":1884989,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T19:02:41.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":true,"shares":1840,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":6604,"source":{"system":"sec-edgar","filing":"0001209191-23-031260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123031260/doc4.xml","form_type":"4"}},{"id":1884988,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T19:02:41.000Z","date":"2023-05-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":3040,"price":6.69,"value":20337.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents the number of shares withheld by and surrendered to the Issuer on May 18, 2023, to satisfy tax withholding obligations that arose in connection with the vesting of the RSU Award."}],"balance_after":4764,"source":{"system":"sec-edgar","filing":"0001209191-23-031260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123031260/doc4.xml","form_type":"4"}},{"id":1884987,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Common Stock","published_at":"2023-05-19T19:02:41.000Z","date":"2023-05-18","kind":"exercise","planned":false,"acquired":true,"shares":7804,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":7804,"source":{"system":"sec-edgar","filing":"0001209191-23-031260","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123031260/doc4.xml","form_type":"4"}},{"id":1966432,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-07T19:45:39.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":44180,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest over 4 years with 2/48 of the total shares underlying the RSU Award vesting on May 18, 2023 and each May 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on August 18, 2023 and each August 18 thereafter; 3/48 of the total shares underlying the RSU Award vesting on November 18, 2023 and each November 18 thereafter; and 4/48 of the total shares underlying the RSU Award vesting each March 10, 2024 and each March 10 thereafter, until fully vested."}],"balance_after":44180,"derivative":{"underlying":"Common Stock","underlying_shares":44180},"source":{"system":"sec-edgar","filing":"0001209191-23-016977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123016977/doc4.xml","form_type":"4"}},{"id":1966431,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-07T19:45:39.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":66773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/48th of the shares subject to the option shall vest monthly over four years from the vesting commencement date of March 3, 2023. The option becomes fully vested on March 3, 2027."}],"balance_after":66773,"derivative":{"exercise_price":10.61,"expiration_date":"2033-03-03","underlying":"Common Stock","underlying_shares":66773},"source":{"system":"sec-edgar","filing":"0001209191-23-016977","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919123016977/doc4.xml","form_type":"4"}},{"id":2289777,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Restricted Stock Units","published_at":"2022-04-27T20:07:54.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":31217,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each Restricted Stock Unit (the \"RSU Award\") represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 12/48th of the total shares underlying the RSU Award vesting on May 18, 2023 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The shares subject to the RSU Award shall vest quarterly over four years, with 12/48th of the total shares underlying the RSU Award vesting on May 18, 2023 and 3/48th of the total shares underlying the RSU Award vesting each subsequent quarter thereafter on August 18, November 18, February 18 and May 18."}],"balance_after":31217,"derivative":{"underlying":"Common Stock","underlying_shares":31217},"source":{"system":"sec-edgar","filing":"0001209191-22-025897","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919122025897/doc4.xml","form_type":"4"}},{"id":2289776,"issuer":{"id":5345,"kind":"organization","name":"Cytek Biosciences, Inc."},"owners":[{"id":91326,"kind":"person","name":"Garland Jonathan Todd","position":1,"cik":"0001924824","reported_name":"Garland Jonathan Todd","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2022-04-27T20:07:54.000Z","date":"2022-04-25","kind":"grant","acquired":true,"shares":46971,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest as follows: 25% of the total shares underlying the option shall vest on April 25, 2023 and 1/48 of the total shares underlying the option shall vest each month thereafter."}],"balance_after":46971,"derivative":{"exercise_price":9.61,"expiration_date":"2032-04-25","underlying":"Common Stock","underlying_shares":46971},"source":{"system":"sec-edgar","filing":"0001209191-22-025897","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1924824/000120919122025897/doc4.xml","form_type":"4"}}]}